Betaine Anhydrous (TMG)

Betaine Anhydrous (TMG) is a commercially used dietary-supplement ingredient or ingredient form. It is commonly positioned for general wellness; specialist nutraceutical, although evidence strength, permitted use and legal claims depend on the exact specification, dose and jurisdiction.

Metabolism
Digestion

Create a custom formulation with this ingredient

Origin of Ingredient

Food-derived, fermentation-derived or manufactured nutraceutical material depending on supplier specification.

History of Ingredient

Betaine Anhydrous (TMG) moved from food, biochemical or specialist use into modern nutraceuticals as purification, fermentation, encapsulation and standardisation technologies developed.

Scientific Makeup of Ingredient

trimethylglycine, a methyl-group donor and osmolyte

UK Legal Claim

• Betaine contributes to normal homocysteine metabolism. Conditions: At least 500 mg betaine per quantified portion; beneficial effect obtained with 1.5 g/day.

EU Legal Claim

• Betaine contributes to normal homocysteine metabolism. Conditions: At least 500 mg betaine per quantified portion; beneficial effect obtained with 1.5 g/day.

US Legal Claim

FDA does not pre-approve ordinary dietary-supplement structure/function claims. Example for regulatory review only (NOT FDA-approved wording): “Supports normal energy and metabolic function.” The marketer must hold substantiation, avoid disease claims, use the DSHEA disclaimer and notify FDA within 30 days after first marketing.

00:00:00

August 24, 2024

Fast Response